GILD
Price
$111.27
Change
-$0.78 (-0.70%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
90.79B
23 days until earnings call
JNJ
Price
$153.25
Change
-$12.60 (-7.60%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
380.22B
14 days until earnings call
Ad is loading...

GILD vs JNJ

Header iconGILD vs JNJ Comparison
Open Charts GILD vs JNJBanner chart's image
Gilead Sciences
Price$111.27
Change-$0.78 (-0.70%)
Volume$382.66K
Capitalization90.79B
Johnson & Johnson
Price$153.25
Change-$12.60 (-7.60%)
Volume$92.92K
Capitalization380.22B
GILD vs JNJ Comparison Chart
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GILD vs. JNJ commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a Buy and JNJ is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (GILD: $112.05 vs. JNJ: $165.84)
Brand notoriety: GILD and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 97% vs. JNJ: 139%
Market capitalization -- GILD: $90.79B vs. JNJ: $380.22B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 3 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • GILD’s FA Score: 3 green, 2 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than GILD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 3 TA indicator(s) are bullish while JNJ’s TA Score has 3 bullish TA indicator(s).

  • GILD’s TA Score: 3 bullish, 5 bearish.
  • JNJ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GILD is a better buy in the short-term than JNJ.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а +4.97% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +1.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.86%. For the same industry, the average monthly price growth was -1.23%, and the average quarterly price growth was -6.74%.

Reported Earning Dates

GILD is expected to report earnings on Apr 24, 2025.

JNJ is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.86% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than GILD($90.8B). JNJ has higher P/E ratio than GILD: JNJ (30.34) vs GILD (16.20). GILD YTD gains are higher at: 22.157 vs. JNJ (15.591). JNJ has higher annual earnings (EBITDA): 23.3B vs. GILD (10.5B). JNJ has more cash in the bank: 22.9B vs. GILD (7.26B). GILD has less debt than JNJ: GILD (25B) vs JNJ (29.3B). JNJ has higher revenues than GILD: JNJ (85.2B) vs GILD (27.1B).
GILDJNJGILD / JNJ
Capitalization90.8B380B24%
EBITDA10.5B23.3B45%
Gain YTD22.15715.591142%
P/E Ratio16.2030.3453%
Revenue27.1B85.2B32%
Total Cash7.26B22.9B32%
Total Debt25B29.3B85%
FUNDAMENTALS RATINGS
GILD vs JNJ: Fundamental Ratings
GILD
JNJ
OUTLOOK RATING
1..100
7924
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
1125
SMR RATING
1..100
8846
PRICE GROWTH RATING
1..100
340
P/E GROWTH RATING
1..100
151
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (19) in the Pharmaceuticals Major industry is in the same range as GILD (35) in the Biotechnology industry. This means that JNJ’s stock grew similarly to GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (11) in the Biotechnology industry is in the same range as JNJ (25) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's SMR Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for GILD (88) in the Biotechnology industry. This means that JNJ’s stock grew somewhat faster than GILD’s over the last 12 months.

GILD's Price Growth Rating (3) in the Biotechnology industry is somewhat better than the same rating for JNJ (40) in the Pharmaceuticals Major industry. This means that GILD’s stock grew somewhat faster than JNJ’s over the last 12 months.

GILD's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for JNJ (51) in the Pharmaceuticals Major industry. This means that GILD’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GILDJNJ
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
42%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
41%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
43%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
41%
Declines
ODDS (%)
Bearish Trend 13 days ago
48%
Bearish Trend 8 days ago
42%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
33%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
37%
View a ticker or compare two or three
Ad is loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABG220.842.67
+1.22%
Asbury Automotive Group
NEM48.280.20
+0.42%
Newmont Corp
NRIM73.22-0.03
-0.04%
Northrim BanCorp
INDI2.04-0.08
-3.55%
indie Semiconductor
GREE0.73-0.09
-10.90%
Greenidge Generation Holdings

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with JNJ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.23%
JNJ - GILD
40%
Loosely correlated
+1.30%
BMY - GILD
36%
Loosely correlated
+1.62%
BIIB - GILD
35%
Loosely correlated
-1.11%
PFE - GILD
31%
Poorly correlated
+0.52%
ABBV - GILD
28%
Poorly correlated
+2.06%
More